Jack Henry (NASDAQ: JKHY) reported Q2 EPS of $0.75, $0.01 better than the analyst estimate of $0.74. Revenue for the quarter came in at $348.6 million versus the consensus estimate of $346.41 million.

According to Kevin Williams, CFO, "Adjusting for the net decrease in deconversion fees in the quarter compared to last year, plus the impact of Alogent, our revenue growth would have been slightly above 8%. Also, adjusting for both of these our operating income would have increased 10% and adjusting for the significant change in the effective tax rate our net income would have also grown 10% for the quarter compared to last year. We still have two more quarters of Alogent revenue to grow over (Q\'3 $7,657 and Q\'4 $6,089)."

For earnings history and earnings-related data on Jack Henry (JKHY) click here.